John M. Wetzel

Person

Athens, OH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Secondary amino anilinic piperidines as MCH1 antagonists and uses t...
- Patent number 7,473,698
- Issue date Jan 6, 2009
- H. Lunbeck A/S
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of GAL3 antagonist for treatment of depression and/or anxiety a...
- Patent number 7,465,750
- Issue date Dec 16, 2008
- H. Lundbeck A/S
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spirocyclic piperidines as MCH1 antagonists and uses thereof
- Patent number 7,335,665
- Issue date Feb 26, 2008
- H. Lundbeck A/S
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted alkyl amido piperidines
- Patent number 7,199,135
- Issue date Apr 3, 2007
- H. Lundbeck A/S
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-imino-2-indolones for the treatment of depression and/or anxiety
- Patent number 7,166,635
- Issue date Jan 23, 2007
- H. Lundbeck A/S
- Michael Konkel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted alkyl amido piperidines
- Patent number 7,105,544
- Issue date Sep 12, 2006
- Synaptic Pharmaceutical Corporation
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted anilinic piperidines as MCH selective antagonists
- Patent number 7,067,534
- Issue date Jun 27, 2006
- H. Lundbeck A/S
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted anilinic piperidines as MCH selective antagonists
- Patent number 6,727,264
- Issue date Apr 27, 2004
- Synaptic Pharmaceutical Corporation
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective melanin concentrating hormone-1 (MCH1) receptor antagonis...
- Patent number 6,720,324
- Issue date Apr 13, 2004
- Synaptic Pharmaceutical Corporation
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds specific for the human α1d adrenergic receptor and...
- Patent number 6,706,716
- Issue date Mar 16, 2004
- Synaptic Pharmaceutical Corporation
- Michael Konkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dihydropyridines and new uses thereof
- Patent number 6,608,086
- Issue date Aug 19, 2003
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of α1C specific compounds to treat benign prostatic hype...
- Patent number 6,602,888
- Issue date Aug 5, 2003
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dihydropyridines and new uses thereof
- Patent number 6,310,076
- Issue date Oct 30, 2001
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydropyridines and new uses thereof
- Patent number 6,211,198
- Issue date Apr 3, 2001
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of alpha-1C specific compounds to treat benign prostatic hyperp...
- Patent number 6,015,819
- Issue date Jan 18, 2000
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
.alpha..sub.1C specific compounds to treat benign prostatic hyperpl...
- Patent number 5,990,128
- Issue date Nov 23, 1999
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of .alpha..sub.1c specific compounds to treat benign prostatic...
- Patent number 5,780,485
- Issue date Jul 14, 1998
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dihydropyridines and new uses thereof
- Patent number 5,767,131
- Issue date Jun 16, 1998
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of .alpha.-1C specific compounds to treat benign prostatic hype...
- Patent number 5,578,611
- Issue date Nov 26, 1996
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of .alpha..sub.1C specific compounds to treat benign prostatic...
- Patent number 5,403,847
- Issue date Apr 4, 1995
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Use of GAL3 receptor antagonists for the treatment of depression an...
- Publication number 20090318504
- Publication date Dec 24, 2009
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GAL3 antagonist for treatment of depression and/or anxiety a...
- Publication number 20070259942
- Publication date Nov 8, 2007
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GALR3 receptor antagonists for the treatment of depression a...
- Publication number 20070054910
- Publication date Mar 8, 2007
- Michael Konkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted anilinic piperidines as MCH selective antagonists
- Publication number 20070043080
- Publication date Feb 22, 2007
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted alkyl amido piperidines
- Publication number 20060217418
- Publication date Sep 28, 2006
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Spirocvclic piperidines as mch1 antagonists and uses thereof
- Publication number 20060173027
- Publication date Aug 3, 2006
- H. Lundbeck A/S
- Mohammad R Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted alkyl amido piperidines
- Publication number 20060084649
- Publication date Apr 20, 2006
- Synaptic Pharmaceutical Corporation
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED ALKYL AMIDO PIPERIDINES
- Publication number 20060041139
- Publication date Feb 23, 2006
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Secondary amino anilinic piperidines as mch1 antagonists and uses t...
- Publication number 20050245743
- Publication date Nov 3, 2005
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes and polymorphs of diaryl-indolone galr3 antagonists
- Publication number 20050192337
- Publication date Sep 1, 2005
- Vrej Jubian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-Aryl piperidines
- Publication number 20050154020
- Publication date Jul 14, 2005
- Synaptic Pharmaceutical Corporation
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-aryl piperidines
- Publication number 20050154022
- Publication date Jul 14, 2005
- H. Lundbeck A/S
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-imino-2-indolones for the treatment of depression and/or anxiety
- Publication number 20050148635
- Publication date Jul 7, 2005
- Michael Konkel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective melanin concentrating hormone-1 (MCH1) receptor antagonis...
- Publication number 20040242609
- Publication date Dec 2, 2004
- Synaptic Pharmaceutical Corporation
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted alkyl amido piperidines
- Publication number 20040186103
- Publication date Sep 23, 2004
- Synaptic Pharmaceutical Corporation
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of GAL3 antagonist for treatment of depression
- Publication number 20040127502
- Publication date Jul 1, 2004
- Synaptic Pharmaceutical Corporation
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GAL3 receptor antagonists for the treatment of affective disorders
- Publication number 20040110821
- Publication date Jun 10, 2004
- Michael J. Konkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds specific for the human alpha1d adrenergic receptor and us...
- Publication number 20040106623
- Publication date Jun 3, 2004
- Synaptic Pharmaceutical Corporation
- Michael Konkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-Imino-2-indolones for the treatement of depression and/or anxiety
- Publication number 20040082615
- Publication date Apr 29, 2004
- Michael Konkel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted alkyl amido piperidines
- Publication number 20040073036
- Publication date Apr 15, 2004
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for the treatment of pain
- Publication number 20030176314
- Publication date Sep 18, 2003
- Carlos C. Forray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Molecules specific for NPFF receptors and uses thereof
- Publication number 20030144310
- Publication date Jul 31, 2003
- Lakmal W. Boteju
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Guanidines which are agonist/antagonist ligands for neuropeptide FF...
- Publication number 20030139431
- Publication date Jul 24, 2003
- Joel K. Kawakami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of GAL3 receptor antagonists for the treatment of depression an...
- Publication number 20030078271
- Publication date Apr 24, 2003
- Thomas P. Blackburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective melanin concentrating hormone-1 (MCH1) receptor antagonis...
- Publication number 20030069261
- Publication date Apr 10, 2003
- Mohammad R. Marzabadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions comprising alpha-1C specific compounds
- Publication number 20030022900
- Publication date Jan 30, 2003
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dihydropyridines and new uses thereof
- Publication number 20020193599
- Publication date Dec 19, 2002
- Synaptic Pharmaceutical Corporation
- Charles Gluchowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ALPHA-1C SPECIFIC COMPOUNDS TO TREAT BENIGN PROSTATIC HYPERP...
- Publication number 20020032219
- Publication date Mar 14, 2002
- CHARLES GLUCHOWSKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds specific for the human alpha1d adrenergic receptor and us...
- Publication number 20020028760
- Publication date Mar 7, 2002
- Michael Konkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

John M. Wetzel

Person

Patents Grantslast 30 patents

Secondary amino anilinic piperidines as MCH1 antagonists and uses t...

Use of GAL3 antagonist for treatment of depression and/or anxiety a...

Spirocyclic piperidines as MCH1 antagonists and uses thereof

Substituted alkyl amido piperidines

3-imino-2-indolones for the treatment of depression and/or anxiety

Substituted alkyl amido piperidines

Substituted anilinic piperidines as MCH selective antagonists

Substituted anilinic piperidines as MCH selective antagonists

Selective melanin concentrating hormone-1 (MCH1) receptor antagonis...

Compounds specific for the human &#x03B1;1d adrenergic receptor and...

Dihydropyridines and new uses thereof

Use of &#x03B1;1C specific compounds to treat benign prostatic hype...

Dihydropyridines and new uses thereof

Dihydropyridines and new uses thereof

Use of alpha-1C specific compounds to treat benign prostatic hyperp...

.alpha..sub.1C specific compounds to treat benign prostatic hyperpl...

Use of .alpha..sub.1c specific compounds to treat benign prostatic...

Dihydropyridines and new uses thereof

Use of .alpha.-1C specific compounds to treat benign prostatic hype...

Use of .alpha..sub.1C specific compounds to treat benign prostatic...

Patents Applicationslast 30 patents

Use of GAL3 receptor antagonists for the treatment of depression an...

Use of GAL3 antagonist for treatment of depression and/or anxiety a...

Use of GALR3 receptor antagonists for the treatment of depression a...

Substituted anilinic piperidines as MCH selective antagonists

Substituted alkyl amido piperidines

Spirocvclic piperidines as mch1 antagonists and uses thereof

Substituted alkyl amido piperidines

SUBSTITUTED ALKYL AMIDO PIPERIDINES

Secondary amino anilinic piperidines as mch1 antagonists and uses t...

Processes and polymorphs of diaryl-indolone galr3 antagonists

4-Aryl piperidines

4-aryl piperidines

3-imino-2-indolones for the treatment of depression and/or anxiety

Selective melanin concentrating hormone-1 (MCH1) receptor antagonis...

Substituted alkyl amido piperidines

Use of GAL3 antagonist for treatment of depression

GAL3 receptor antagonists for the treatment of affective disorders

Compounds specific for the human alpha1d adrenergic receptor and us...

3-Imino-2-indolones for the treatement of depression and/or anxiety

Substituted alkyl amido piperidines

Compounds for the treatment of pain

Molecules specific for NPFF receptors and uses thereof

Guanidines which are agonist/antagonist ligands for neuropeptide FF...

Use of GAL3 receptor antagonists for the treatment of depression an...

Selective melanin concentrating hormone-1 (MCH1) receptor antagonis...

Compositions comprising alpha-1C specific compounds

Dihydropyridines and new uses thereof

USE OF ALPHA-1C SPECIFIC COMPOUNDS TO TREAT BENIGN PROSTATIC HYPERP...

Compounds specific for the human alpha1d adrenergic receptor and us...

Compounds specific for the human α1d adrenergic receptor and...

Use of α1C specific compounds to treat benign prostatic hype...